The effects of acute and chronic nicotine hydrogen (+)-tartrate administration and subsequent withdrawal on rat liver tryptophan pyrrolase activity and their comparison with those of morphine, phenobarbitone and ethanol

Biochem J. 1975 Jun;148(3):425-32. doi: 10.1042/bj1480425.

Abstract

Acute administration of nicotine hydrogen (+)-tartrate enhances the activity of rat liver tryptophan pyrrolase by a hormonal mechanism. Chronic nicotine treatment inhibits, and subsequent withdrawal enhances, the pyrrolase activity. The inhibition during chronic treatment is not due to a defective apoenzyme synthesis nor a decreased cofactor availability. Regeneration of liver NADP+ in vitro and in vivo reverses the inhibition. Chronic nicotine administration increases the liver NADPH concentration. The above effects of nicotine resemble to a remarkable degree those previously shown for morphine, phenobarbitone and ethanol. All effects are compared, and their possible significance in relation to drug dependence is discussed.

Publication types

  • Comparative Study

MeSH terms

  • Animals
  • Cycloheximide / pharmacology
  • Dactinomycin / pharmacology
  • Ethanol / pharmacology
  • Humans
  • Hydrocortisone / pharmacology
  • Liver / drug effects*
  • Liver / enzymology
  • Male
  • Morphine / pharmacology
  • NADP / metabolism
  • Nicotinyl Alcohol / administration & dosage
  • Nicotinyl Alcohol / pharmacology*
  • Phenobarbital / pharmacology
  • Premedication
  • Pyridines / pharmacology*
  • Rats
  • Substance Withdrawal Syndrome
  • Time Factors
  • Tryptophan / pharmacology
  • Tryptophan Oxygenase / metabolism*

Substances

  • Pyridines
  • Dactinomycin
  • Ethanol
  • NADP
  • Morphine
  • Tryptophan
  • Cycloheximide
  • Nicotinyl Alcohol
  • Tryptophan Oxygenase
  • Hydrocortisone
  • Phenobarbital